Results 171 to 180 of about 206,287 (344)
Addition of rifampicin in persistent Haemophilus influenzae type B meningitis. [PDF]
, 1986 Caroline Haines, M Patfield
openalex +1 more source
Host–pathogen interactions of nontypeable Haemophilus influenzae: from commensal to pathogen
FEBS Letters, 2016 B. L. Duell, Yu-Ching Su, K. Riesbeck
semanticscholar +1 more source
Microbial Contributions to Primate Reproduction
Evolutionary Anthropology: Issues, News, and Reviews, Volume 35, Issue 1, March 2026.ABSTRACT Reproduction is a complex process, and microbes play a far greater role than previously imagined. This review explores the ways that microbiomes influence the rich tapestry of reproductive processes and outcomes within the primate lineage, including pre‐copulatory and post‐copulatory mechanisms.
Silvia Carboni +2 more
wiley +1 more source
Comparing Haemophilus influenzae Type b Conjugate Vaccine Schedules
, 2013 Nicola Low +6 more
openalex +1 more source
Immunogenicity and Efficacy of Different Haemophilus influenzae type b Vaccines [PDF]
, 2014 Naheed Mojgani
openalex +1 more source
MedComm – Biomaterials and Applications, Volume 5, Issue 1, March 2026.The review provides a comprehensive analysis of microbiome‐mediated oncogenic mechanisms in various cancers, emphasizing the unique therapeutic strategies facilitated by nanotechnology. It aims to fill this gap by systematically reviewing nanotechnology‐driven strategies for microbiome elimination, with a focus on their ability to improve the cold TME ...
Yumei Gan, Yan Zhang, Xia Dong, Feng Lv
wiley +1 more source
UPPER RESPIRATORY DYSBIOSIS IN CHILDREN
Фундаментальная и клиническая медицина, 2017 Studies of upper respiratory metagenome in children identied Firmicutes as a dominant bacterial group and Proteobacteria, Bacteroidetes, Actinobacteria and Fusobacteria as other main groups, with the population, environmental, and seasonal
ELENA V. Shabaldina, ANDREY V. Shabaldin
doaj
American Journal of Hematology, Volume 101, Issue 2, Page 242-254, February 2026.ABSTRACT Iptacopan is a first‐in‐class, oral, selective inhibitor of complement factor B that has demonstrated positive efficacy across several complement‐driven diseases. Here we evaluate the efficacy and safety of iptacopan monotherapy in adult patients with primary immune thrombocytopenia (ITP) and primary cold agglutinin disease (CAD). We performed
Alexander Röth +13 more
wiley +1 more source